Boehringer Ingelheim


Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim we are giving patients new hope, by taking cancer on.

We are dedicated to collaborating with the oncology community on a shared journey to deliver leading science. Our goal is treatment breakthroughs that can transform the lives of patients and help win the fight against cancer.

We are searching for, developing and accelerating novel therapeutic approaches that address unmet needs in lung and gastrointestinal cancers. Our focus is on advancing research programs designed to deliver first-in-class treatments with breakthrough potential.

To find out more about our ongoing collaborations, approved and investigational compounds, oncology meetings and congresses, symposia and other activities sponsored by Boehringer Ingelheim, please follow the link to

Boehringer Ingelheim has produced educational slide decks that discuss the epidemiology, disease classification and treatment guidelines of several sub-types of lung and gastro-intestinal cancers (such as adeno and squamous non-small cell lung cancer, colorectal cancer, gastric cancer) and other topics. To preview and download those slides, please visit our slide bank on